Lafutidine

Independent reference data for Lafutidine (CAS 118288-08-7), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.

Synonyms and trade names

lafutidine; 118288-08-7; FRG-8813; DTXSID0046434; FRG 8813; Lafutidina; 49S4O7ADLC; DTXCID8026434; N-(4-(4-Piperidinylmethyl)pyridyl-2-oxy)butenyl-2-(furfurylsulfinyl)acetamide; loctidine; lafutidinum; RefChem:798397; A02BA08; 601-513-8; rac Lafutidine; (Z)-Lafutidine

GHS hazard classification

Reported hazard statements	H302 (100%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

What the public record says

Lafutidine · CAS 118288-08-7 · C22H29N3O4S. UNII 49S4O7ADLC.

Source: PubChem / Wikidata; the batch COA governs where values differ.